TechPipeline logo
Magnifying glass icon
By format
Start-ups

From Strategic Plan to Execution: Charting a Course for Your Start-Up’s Exit Event

What’s included

Access to the on-demand video with closed captions and presentation materials.

This program will delve into exit planning, the types of exits and the pros and cons of each, determining the right time to exit, and much more

$197.00

Here’s a quick look at the agenda details:

  • Why do so many entrepreneurs focus on the exit?
  • What is the reality of exits – statistics on acquisitions, IPOs, price ranges, age of company
  • Types of exits
    • “Aqui-hires”
    • Lifestyle/ Mature company sales – multiples of EBITA
    • Big exits – acquisitions and IPOs
    • Distressed/bankruptcy
  • Types of Buyers
    • Strategic
    • Private Equity
  • Being prepared:
    • Fundamentals – revenue, profit, IP protection, growth rate
    • Key milestones – FDA, major customer
    • Paperwork – the details
    • Positioning and relationships
  • What is involved in a transaction?
    • Finding a buyer
    • Due Diligence
    • Preparing and negotiating legal documents
    • Signing and Closing a Deal
    • Post-Closing (What happens next?)
  • How long does the process take and what kinds of advisors do I need to engage?
  • Real-world examples

Even at the point of forming a university-based start-up company, future investors want to know your exit plan for the company. Whether by merger or acquisition, an initial public offering (IPO), a management buyout, or SPAC (special purpose acquisition company), charting your exit strategy is a critical aspect of any start-up’s strategic plan.

Not every type of exit is appropriate for every business. Each strategy is unique and holds specific regulatory and accounting requirements that should be considered when forming and growing the company. This insightful program will help you navigate the twists and turns to make an informed decision on the exit strategy that is right for you and your company.

Join expert attorney Christopher T. Turek of Greenberg Traurig’s Corporate Practice in the firm’s Washington, D.C. office, and entrepreneur and nationally recognized authority on technology transfer venture creation Gerard Eldering, CEO of Perfusion Medical, when they delve into exit planning, the types of exits and the pros and cons of each, determining the right time to exit, and much more.

Program Leaders

Greenberg Traurig
CEO Perfusion Medical

What’s included

Access to the on-demand video with closed captions and presentation materials.

This program will delve into exit planning, the types of exits and the pros and cons of each, determining the right time to exit, and much more

$197.00

Already a subscriber? Log in

Be an “Insider”

Purchase our live and on-demand webinars individually or subscribe to TechPipeline resources at the Pro or Insider level. Subscribers enjoy free, unlimited access to our extensive collection of webinars and a lot more.

Explore our Subscriptions page to find the right subscription plan for you and your team.
Subscribe